KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Inventory Average (2018 - 2025)

Historic Inventory Average for Alnylam Pharmaceuticals (ALNY) over the last 8 years, with Q4 2025 value amounting to $79.1 million.

  • Alnylam Pharmaceuticals' Inventory Average rose 233.4% to $79.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $79.1 million, marking a year-over-year increase of 233.4%. This contributed to the annual value of $80.6 million for FY2025, which is 383.35% down from last year.
  • Per Alnylam Pharmaceuticals' latest filing, its Inventory Average stood at $79.1 million for Q4 2025, which was up 233.4% from $73.5 million recorded in Q3 2025.
  • Over the past 5 years, Alnylam Pharmaceuticals' Inventory Average peaked at $130.4 million during Q1 2023, and registered a low of $68.6 million during Q2 2025.
  • Moreover, its 5-year median value for Inventory Average was $86.4 million (2022), whereas its average is $89.8 million.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 5820.15% in 2023, then tumbled by 2979.09% in 2024.
  • Over the past 5 years, Alnylam Pharmaceuticals' Inventory Average (Quarter) stood at $92.1 million in 2021, then soared by 32.66% to $122.2 million in 2022, then decreased by 24.35% to $92.5 million in 2023, then dropped by 16.45% to $77.2 million in 2024, then rose by 2.33% to $79.1 million in 2025.
  • Its Inventory Average stands at $79.1 million for Q4 2025, versus $73.5 million for Q3 2025 and $68.6 million for Q2 2025.